Skip to main content
Livermore
Livermore
ZHEN

Xenon Pharmaceuticals Inc.

XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001582313

In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Xenon Pharmaceuticals Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of XENE: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders1322151+21
Shares49.2M72.0K57.0M+7.91M (+16.1%)
Value$1.50B$2.20M$1.73B+$235.7M (+15.7%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (38)

Institutions that held Xenon Pharmaceuticals Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to XENE in Q2 2022
InstitutionSharesValue% of portfolio
Redmile Group, LLC1,639,344$49.9M1.90%
Eventide Asset Management, LLC469,700$14.3M0.31%
Avidity Partners Management LP450,000$13.7M0.31%
Woodline Partners LP228,928$6.96M0.11%
Tri Locum Partners LP166,399$5.06M2.08%
EAM Global Investors LLC150,489$4.58M1.12%
LMR Partners LLP100,000$3.04M0.06%
Integral Health Asset Management, LLC97,281$2.96M0.61%
UBS Oconnor LLC96,208$2.93M0.03%
Monashee Investment Management LLC85,000$2.59M0.94%
Bridger Management, LLC77,400$2.35M0.53%
Maven Securities LTD55,645$1.69M0.30%
Advisory Research Inc35,000$1.06M0.10%
Alps Advisors Inc31,498$958.0K0.01%
ExodusPoint Capital Management, LP31,332$953.0K0.01%
VR Adviser, LLC30,000$913.0K0.18%
Tekla Capital Management LLC29,710$904.0K0.04%
Jefferies Group LLC27,828$846.5K0.02%
Sanders Morris Harris LLC24,500$754.0K0.16%
SG Americas Securities, LLC22,453$683.0K0.01%
Chartwell Investment Partners, LLC21,508$654.0K0.03%
Tudor Investment Corp Et Al20,336$619.0K0.02%
Velan Capital Investment Management LP20,000$608.0K0.64%
HRT Financial LP19,902$605.0K0.01%
Natixis Advisors, L.P.19,379$590.0K0.00%
Employees Retirement System of Texas16,001$487.0K0.01%
Occudo Quantitative Strategies LP10,945$333.0K0.03%
Public Employees Retirement Association of Colorado10,633$323.0K0.00%
De Burlo Group Inc10,000$304.0K0.09%
Laurion Capital Management LP10,000$304.0K0.01%
Main Street Research LLC10,000$304.0K0.08%
Birchview Capital, LP10,000$304.0K0.22%
Pinz Capital Management, LP10,000$304.0K0.21%
Sandia Investment Management LP9,900$301.0K0.04%
Y-Intercept (Hong Kong) Ltd7,324$223.0K0.03%
Squarepoint Ops LLC7,050$214.0K0.00%
Advisors Asset Management, Inc.5,048$154.0K0.00%
Simplex Trading, LLC940$28.0K0.00%

Sold out (17)

Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of XENE in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Suvretta Capital Management, LLC692,000$21.2M
Two Sigma Investments, LP232,650$7.11M
Invesco Ltd.198,701$6.07M
Renaissance Technologies LLC150,777$4.61M
Ci Investments Inc.100,705$3.08M
Ghost Tree Capital, LLC100,000$3.06M
Affinity Asset Advisors, LLC80,000$2.45M
Jump Financial, LLC30,101$920.0K
Royal Bank of Canada24,313$743.0K
Granite Point Capital Management, L.P.20,000$611.0K
Jane Street Group, LLC16,117$493.0K
Dynamic Technology Lab Private Ltd13,993$428.0K
Teacher Retirement System of Texas8,545$261.0K
Connor, Clark & Lunn Investment Management Ltd.7,658$234.0K
Aquatic Capital Management LLC400$12.0K
Brown Brothers Harriman & Co294$9.00K
Barclays PLC191$6.00K

Not filed for Q2 2022 yet (2)

Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XENE in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Susquehanna Fundamental Investments, LLC45,647$1.40M
Parametric Portfolio Associates LLC26,338$805.0K